NO20076075L - 4-anilino-3-kinolinkarbonitriler for behandling av cancer - Google Patents

4-anilino-3-kinolinkarbonitriler for behandling av cancer

Info

Publication number
NO20076075L
NO20076075L NO20076075A NO20076075A NO20076075L NO 20076075 L NO20076075 L NO 20076075L NO 20076075 A NO20076075 A NO 20076075A NO 20076075 A NO20076075 A NO 20076075A NO 20076075 L NO20076075 L NO 20076075L
Authority
NO
Norway
Prior art keywords
cancer
carbonitriles
anilino
quinoline
treatment
Prior art date
Application number
NO20076075A
Other languages
English (en)
Norwegian (no)
Inventor
Frank Charles Boschelli
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37575124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20076075(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20076075L publication Critical patent/NO20076075L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20076075A 2005-06-24 2007-11-27 4-anilino-3-kinolinkarbonitriler for behandling av cancer NO20076075L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69367105P 2005-06-24 2005-06-24
PCT/US2006/023063 WO2007001839A2 (en) 2005-06-24 2006-06-13 4-anilino-3-quinolinecarbonitriles for the treatment of cancer

Publications (1)

Publication Number Publication Date
NO20076075L true NO20076075L (no) 2008-03-18

Family

ID=37575124

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076075A NO20076075L (no) 2005-06-24 2007-11-27 4-anilino-3-kinolinkarbonitriler for behandling av cancer

Country Status (20)

Country Link
US (1) US20070010527A1 (ru)
EP (1) EP1893209A2 (ru)
JP (1) JP2008546777A (ru)
KR (1) KR20080027275A (ru)
CN (1) CN101252931A (ru)
AR (1) AR057403A1 (ru)
AU (1) AU2006262591A1 (ru)
BR (1) BRPI0611977A2 (ru)
CA (1) CA2610209A1 (ru)
CR (1) CR9539A (ru)
EC (1) ECSP078015A (ru)
GT (1) GT200600268A (ru)
IL (1) IL187792A0 (ru)
MX (1) MX2007016542A (ru)
NI (1) NI200700323A (ru)
NO (1) NO20076075L (ru)
PE (1) PE20070323A1 (ru)
RU (1) RU2007143434A (ru)
TW (1) TW200730177A (ru)
WO (1) WO2007001839A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2449197T5 (es) * 2005-07-01 2022-04-28 Wyeth Llc Formas cristalinas de 4-[(2,4-dicloro-5-metoxifenil)amino]-6-metoxi-7-[3-(4-metil-1-piperazinil)propoxi]-3- quinolincarbonitrilo y procedimientos de preparación de las mismas
WO2013187967A1 (en) * 2012-06-15 2013-12-19 Institute For Cancer Research D/B/A The Research Institute Of Fox Case Cancer Center ("Fox Chase Cancer Center") Sensitization of cancer cells to dna damage by inhibiting kinases essential for dna damage checkpoint control
WO2017134679A1 (en) * 2016-02-03 2017-08-10 Msn Laboratories Private Limited Novel crystalline polymorphs of 4-[(2.4-dichioro-5-methoxvphenvl)aniinol- 6-methoxv-7-13-(4-methyl-l-piperazinvl)propoxvl-3-quinolinecarbonitrile and process for preparation thereof
CN107433391B (zh) * 2017-07-03 2020-01-17 武汉逸飞激光设备有限公司 一种基于图像识别的焊接校准方法及系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
US6432979B1 (en) * 1999-08-12 2002-08-13 American Cyanamid Company Method of treating or inhibiting colonic polyps and colorectal cancer
US6384051B1 (en) * 2000-03-13 2002-05-07 American Cyanamid Company Method of treating or inhibiting colonic polyps
UA77200C2 (en) * 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
EP1680119A1 (en) * 2003-11-06 2006-07-19 Wyeth 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)

Also Published As

Publication number Publication date
RU2007143434A (ru) 2009-07-27
WO2007001839A2 (en) 2007-01-04
BRPI0611977A2 (pt) 2010-10-13
IL187792A0 (en) 2008-11-03
CA2610209A1 (en) 2007-01-04
AU2006262591A1 (en) 2007-01-04
MX2007016542A (es) 2008-03-04
WO2007001839A3 (en) 2007-04-26
AR057403A1 (es) 2007-12-05
TW200730177A (en) 2007-08-16
NI200700323A (es) 2008-06-25
EP1893209A2 (en) 2008-03-05
CN101252931A (zh) 2008-08-27
KR20080027275A (ko) 2008-03-26
GT200600268A (es) 2007-06-18
CR9539A (es) 2008-02-20
JP2008546777A (ja) 2008-12-25
ECSP078015A (es) 2008-01-23
US20070010527A1 (en) 2007-01-11
PE20070323A1 (es) 2007-05-04

Similar Documents

Publication Publication Date Title
NO20063449L (no) Substituerte heterocykler og deres anvendelse
NO20091864L (no) Forbindelser for inhibering av mitotisk progresjon
WO2009155121A3 (en) Inhibitors of pi3 kinase
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
WO2005110994A8 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
EA201691142A1 (ru) Ингибиторы мек и способы их применения
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
NO20082730L (no) Morfolinopyrimidinderivater og deres anvendelse i terapi
NO20061743L (no) Kinazolinderivater
NO20085217L (no) Effektive pyrimidinderivater i behandlingen av kreft
WO2007044724A3 (en) Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20080150L (no) Inhibitorer av AKT-aktivitet
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20076195L (no) Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer
WO2008013987A3 (en) N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
NO20076197L (no) Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander
NO20082496L (no) Pyrazinderivater
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
TNSN05306A1 (en) Substituted pyrrole derivatives.
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application